Anti-amyloid therapies: Practical insights and first experiences
A Webinar by Dr. Aurélien Lathulière, University Hospital of Geneva
The potential approval of anti-amyloid monoclonal antibody therapies for Alzheimer’s disease in Switzerland represents a major milestone in dementia care, but also brings new challenges for healthcare systems. In this webinar, , neurologist at the Memory Center of Geneva University Hospitals, will share practical strategies for preparing healthcare infrastructure, addressing potential bottlenecks, and integrating these therapies into existing care structures. He will also present firsthand early experiences in applying anti-amyloid monoclonal therapy in people with Alzheimer’s disease.
The webinar is hosted by (Inselspital Bern / Praxis St. Gallen) and offers a platform for shared learning and discussion, enabling participants to exchange insights and experiences.
Event details:
- Date: 15.01.2026
- Time: 12:00
- Duration: 50 minutes (includes Q&A)
- Location: Online (link to be provided upon registration)
- Costs: Free of charge
Register today:
The Dementia Update - Clinical Series is a monthly online event developed in collaboration with the Designed for clinicians and healthcare professionals working with people affected by dementia, each session covers a clinically relevant topic and includes an interactive discussion with Q&A. The series fosters knowledge exchange across and within clinical disciplines and is hosted by a representative of the Swiss Memory Clinics.
About the speaker
Dr. Aurélien Lathulière is featured on our community platform’s expert list. Visit his profile to explore his research interests, ongoing projects, publications, and potential collaboration opportunities.
